Glycanostics

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

Digistain

This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.

Thrive Earlier Detection

This digital health company develops a multi-cancer liquid biopsy test to help healthcare providers detect various cancers through early-stage blood screening.

InterVenn BioSciences

This company develops glycoproteomic diagnostic tests and an AI-driven analysis platform for clinicians and biopharmaceutical partners to improve disease detection and treatment.

Mercy BioAnalytics

This company develops blood-based liquid biopsy tests for early cancer detection, serving healthcare providers, pharmaceutical companies and clinical trial organisers.

Oncoliq

This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.

PrognomiQ

This healthcare company develops multi-omics blood tests for the early detection and monitoring of cancer and complex diseases for clinical health systems.

Epigenomics

This molecular diagnostics company develops blood-based liquid biopsy tests for the early detection and screening of cancer for healthcare providers and clinical laboratories.